*HomeU.S. Government Accountability Office*
Menu

      close


          
          
                          	
				
				
	
	
					Reports & Testimonies
									
																				
				
				
	
	
								Reports & Testimonies
													
																												
																						
							
																Recommendations Database
							
																												
																						
							
																Month in Review
							
																												
																						
							
																Order Copies
							
																												
																						
							
																Restricted Reports
							
																												
																						
							
																View Topics
							
																												
																						
							
																View Agencies
							
																												
																						
							
																Bid Protests & Appropriations Law
									
																				
				
				
	
	
								Bid Protests & Appropriations Law
													
																												
																						
							
																Bid Protests
							
																												
																						
							
																Appropriations Law
							
																												
																						
							
																Federal Vacancies Reform Act
							
																												
																						
							
																Other Legal
							
																												
																						
							
																About
									
																				
				
				
	
	
								About
													
																												
																						
							
																What GAO Does
							
																												
																						
							
																U.S. Comptroller General
							
																												
																						
							
																Careers
							
																												
																						
							
																Contact UsFor Congress
                                
                          
        
                Press Center
                                
                          
        
                Careers
                                
                          
        
                BlogSearch Breadcrumb
        Home
                            Reports & Testimonies
                            Science & Tech Spotlight: At-Home Tools To Diagnose Alzheimer's, Parkinson's, and Related Diseases
    Science & Tech Spotlight:
                          At-Home Tools to Diagnose Alzheimer's, Parkinson's, and Related Diseases **GAO-24-107306**
        Published: Mar 25, 2024. Publicly Released: Mar 25, 2024.Jump To:
    Jump ToElder Abuse
          Services for Older Adults
          State and Local-Level Drivers and Trends
          State and Local Fiscal Projections
          Federal Borrowing
          Managing the Debt
          Summary of Funding Provisions
          Auditing the Government's Books
          Unpacking the Financial Report
          Highlights
          Recommendations
          Background
          About This Work
          About This Work
          Trends
          About the Center
          Why It's High Risk
          What Remains To Be Done
          Key Reports
          Newest COVID-Related Reports
          AI Use Cases
          Flood Insurance
          Past Pandemic-Related Reports
          CARES Act Oversight Reports
          All COVID-19 Reports
          Report Suspected Fraud
          Subjects
          How to Get Notified
          Past Reports
          Public Health Threats
          Explore the FY 2022 and 2023 Funds
          Lessons Learned
          Agency Reports
          Recent Reports
          Recommendations
          Supplemental Material
          Full Report
          Additional Data
          View Decision
          Downloads
          Previously Identified Actions
          Related Pages
          Associated Agencies
          Tough Choices and Opportunities Ahead
          Americas Fiscal Future Key Areas
          Retirement Security Key Areas
          Current List
          About The High Risk List
          Area Ratings
          Previous High Risk Products
          Search Federal Vacancies
          Past Federal Vacancies
          Violation Letters
          About the Yellow Book
          Advisory Council
          Related Resources
          Comment Letters
          Related Publications
          Contacts and Resources
          Major Issues Facing the Nation
          Meeting Strategic Challenges
          Additional Resources
          Resources
          GAO Contacts
          Mission Teams
          Operations and Staff Offices
          Organization Chart
          Why a Career at GAO?
          Am I Qualified?
          Company Culture
          Reasonable Accommodations
          Video Gallery
          Paid Internships
          Student Volunteers
          Professional Development Program
          Advancement
          Executive Candidate Program
          Summer Associates
          Externships
          Benefits
          Contacts
                    Fast Facts
              Neurodegenerative diseases affect about 7 million people in the U.S., with cases expected to increase.

This *Spotlight* covers cognitive assessment apps and wearable sensors designed for home use. They can collect data on patients' cognitive and motor abilities and help detect symptoms of Alzheimer's and other neurodegenerative diseases.

Doctors can use data from these tools to diagnose diseases earlier and more accurately, and these tools can reduce the number of clinic visits for patients. But, some patients may not have access to smartphones or other technology required to use them, and apps that collect health data raise privacy concerns.

close up of someone's hands holding a smartphone
Skip to Highlights
Highlights
  Why This Matters

Neurodegenerative diseases such as Alzheimer’s and Parkinson’s can make day-to-day tasks challenging because they may affect cognitive, motor, and social function. Neurodegenerative diseases affect about 7 million people in the U.S. Researchers expect cases to increase as the population ages. Earlier detection of these diseases may help health care providers treat patients before the onset of severe symptoms and slow disease progression.

Key Takeaways

At-home tools may facilitate earlier detection of neurodegenerative diseases.
	These tools can be a cost-effective way to collect information that is difficult to gather in a clinical setting.
	Health care providers can use information from at-home tools to help diagnose neurodegenerative disease, but such tools are not a replacement for clinical care.The Technology

**What is it?**At-home tools collect and analyze patient data on certain indicators that relate to cognitive ability—memory, reasoning, and language—and motor function. This includes walking, writing, stability, and the presence of tremors. Tools such as digital cognitive assessments and wearable sensors have the potential to help health care providers detect and diagnose neurodegenerative diseases earlier and more accurately. The tools help assess patients in an environment more reflective of daily life, detect indicators that are challenging to observe in a clinical setting, and collect data on patients’ health over time. Traditional diagnostic approaches—which occur in a clinical setting such as a physician’s office—can be more invasive, less convenient, and may not identify these symptoms until the disease is more advanced.



**Figure 1: Patient and health care provider use of at-home tools**

**How does it work?**Digital cognitive assessments use web- or application-based technologies to gather data on a patient’s cognitive abilities. For example, one activity asks patients to memorize objects and their position in a pictured room.

Wearable sensors worn on or near the body measure a range of indicators. Sensors on the hands, wrists, or ankles can collect data on the speed and direction of movements—such as hand tremors, sway, or postural adjustments—that may be indicative of neurodegenerative disease. Smartphones equipped with movement sensors can collect similar data when worn near the body. Researchers found that smartphone sensors can identify whether a person exhibits symptoms associated with Parkinson’s disease based on the way they move.

**How mature is it?**Multiple manufacturers of digital cognitive assessments—which could be administered at-home—have registered with the Food and Drug Administration. However, such at-home assessments are not widely commercially available, and more research is needed on their accuracy.

Wearable sensors vary in their maturity and use. Specifically, sensors worn on the body are an established tool to assess mobility. Researchers call for further studies to investigate the accuracy of smartphone-based sensors prior to applying them more broadly in diagnosis.

Opportunities

**Provide data to support early diagnosis.**Providers can use data from at-home tools to inform earlier or more appropriate interventions to slow cognitive decline and improve symptom management. As technologies mature, patients could also potentially use insights from at-home tools to decide whether they need to consult a provider.
	**Reduce time and cost.**At-home tools can be a practical and cost-effective way to reduce the number of clinic visits in the early stages of a disease when symptoms are still ambiguous. Because the tools can be used remotely, patients can reduce travel time and cost, especially if they live far from a clinic or have limited mobility.
	**Provide easier access to diagnosis.**At-home tools could help improve access to diagnostic information if they are self-administered, which can be particularly helpful in instances where a patient has health care access issues.Challenges

**Limited testing.**Some tools were designed for use at the clinic and researchers have conducted limited testing for at-home use. For example, quality control testing of at-home digital cognitive assessments lags behind those delivered in a clinical setting, but testing is critical to understand a tool’s reliability.
	**Digital divide.**At-home tools may be less useful and less widely adopted if patients do not understand how they work or do not have devices to access them. This challenge could contribute to disparities in diagnosis.
	**Data privacy and security.**Data could be sold, shared without consent, or accessed via data breaches, although data covered by the Health Insurance Portability and Accountability Act of 1996 are provided some additional safeguards.Policy Context and Questions

What are the possible policy implications for existing federal programs such as Medicare, Medicaid, and Social Security Insurance?
	What strategies, if any, might help enhance the benefits and use of at-home tools?
	What oversight or resources could help ensure the tools do not exacerbate health disparities and the digital divide?
	What safeguards could protect data privacy and security?Selected GAO Work

Science & Tech Spotlight: Wearables, GAO-24-107303

Technology Assessment: Artificial Intelligence in Health Care, GAO-22-104629

Selected References

Ohman et al., “Current Advances in Digital Cognitive Assessment for Preclinical Alzheimer’s Disease,”*Alzheimer’s and Dementia Diagnosis*,*Assessment and Disease Monitoring*, (2021) doi: 10.1002/dad2.12217.

Adams et al., “Digital Technology in Movement Disorders: Updates, Applications, and Challenges,”*Current Neurology and Neuroscience Reports,*vol. 21, no. 4(2021).

For more information, contact Karen L. Howard, PhD at (202) 512-6888 or howardk@gao.gov.

Full Report
    Full Report (2 pages)
              Accessible PDF (2 pages)
GAO Contacts
    
      Karen Howard
            
            Director
      
            howardk@gao.gov
      
            (202) 512-6888
Office of Public Affairs
    
      Chuck Young
            
            Managing Director
      
            youngc1@gao.gov
      
            (202) 512-4800
Topics
    
      Health CareAlzheimer's diseaseDiseasesHealth careHealth care providersNeurologyNeurosciencePatient careScience and technologyScience and technology issuesPrivacy
                                                      MultimediaPodcasts
    
      At-Home Testing Tools for Alzheimer's, Parkinson's, and Other Neurodegenerative Diseases
    Monday, March 25, 2024
      
            Transcript
 Receive GAO Updates
  Stay informed as we add new reports & testimonies.

    GAO Logo
      U.S. Government Accountability Office


                                   Column 1
                            Press Center
                              Contact Us
                              Inspector General
                              Restricted Reports
                              Column 2
                            Copyright & Terms of Use
                              Privacy Policy
                              Accessibility
                              Sitemap
                              Column 3
                            FOIA Requests
                              Scam Alerts
                              No FEAR Act Data
                              Health Care Advisory Committees